• Mayo Clinic wins Arthritis Foundation grant for shoulder replacement research

    Updated: 2011-06-28 20:43:28
    Thousands of people have shoulder replacement surgery each year, making it one of the most common types of joint replacement in the United States, yet there is no standard rehabilitation protocol for patients. Some get physical therapy after surgery; some … Continue reading →

  • Birth Outcomes Good in Mothers With MS

    Updated: 2011-06-27 20:30:00
    Women with multiple sclerosis can navigate labor and delivery as successfully as healthy women, a Canadian retrospective cohort study found.

  • Radiation Oncology Treatment Center Opens in Northfield

    Updated: 2011-06-27 14:37:47
    Journalists:  For links to web-video and audio files, see the bottom of this post.   Mayo Clinic is hosting a grand opening ceremony for its new radiation oncology treatment center in Northfield, Minn. on Monday, June 27, at 3 p.m. The … Continue reading →

  • Mayo Clinic Offers Baseline Concussion Testing to Arizona High School Athletes

    Updated: 2011-06-23 19:52:43
    As knowledge about the dangers of concussions in sports continues to grow, Mayo Clinic will make baseline concussion testing available at no cost to more than 100,000 high school student athletes in Arizona leading up to the 2011-2012 sports season. … Continue reading →

  • Mayo Clinic reacts to U.S. Supreme Court Prometheus Ruling

    Updated: 2011-06-22 16:32:13
    In June 2004, Prometheus Laboratories, Inc. sued Mayo Clinic in federal district court in California, alleging that a planned Mayo Medical Laboratories diagnostic test infringed two patents held by Prometheus. Mayo has always maintained that Prometheus’s patents are invalid and … Continue reading →

  • Merck KGaA Throws in Towel on Cladribine for MS

    Updated: 2011-06-22 16:30:00
    Facing skepticism from U.S. and European regulators, Merck KGaA has given up efforts to gain approval for the oral immunosuppressant drug cladribine for multiple sclerosis, the company announced.

  • Rheumatoid arthritis, psoriasis drugs may cut diabetes risk

    Updated: 2011-06-22 02:49:32
    A study by researchers at Brigham and Women’s Hospital in Boston suggests some drugs used to treat rheumatoid arthritis and psoriasis may also lower those patients’ risk of developing diabetes. The research appears in the June 22/29 issue of JAMA. … Continue reading →

  • Mayo Clinic Developing Artificial Pancreas to Ease Diabetes Burden

    Updated: 2011-06-21 21:23:47
    Journalists: For links to web-video and audio files, see the bottom of this post. The 25.8 million Americans who have diabetes may soon be free of finger pricks and daily insulin dosing. Mayo Clinic endocrinologists Yogish Kudva, M.B.B.S., and Ananda … Continue reading →

  • Annual Update in Nephrology and Kidney/Pancreas Transplantation

    Updated: 2011-06-21 15:17:59
    On September 30 and October 1, 2011 the Mayo School of Continuous Professional Development will be conducting its Annual Update in Nephrology and Kidney/Pancreas Transplantation course at the Graves 601 Hotel in Minneapolis, MN. This course is a two-day course … Continue reading →

  • Mayo Makes Recommendations to Patients Taking Simvastatin Therapy

    Updated: 2011-06-16 15:19:19
    The Food and Drug Administration last week released a warning last week about using a high dose of the cholesterol-lowering medication simvastatin (Zocor), as a result of concerns about muscle damage. Mayo Clinic’s recommendations to patients are the same as … Continue reading →

  • Mayo Clinic Makes Recommendations to Patients Taking Niacin

    Updated: 2011-06-16 14:16:10
    In late May, the National Institutes of Health announced it was stopping early the AIM-HIGH study, a study looking at the potential added benefit of niacin therapy for patients with known heart disease who also had a low HDL or … Continue reading →

  • Yellow Fever Vaccine Risky for MS Patients

    Updated: 2011-06-14 16:26:22
    The yellow fever vaccine has been linked with more than a 10-fold increase in rates of MS exacerbation in a small study.

  • Mayo Clinic Gastroenterology and Hepatology Board Review

    Updated: 2011-06-14 15:38:41
    On September 8-11, 2011, the Mayo School of Continuous Professional Development will be conducting its Gastroenterology and Hepatology Board Review course at the Westin Chicago River North in Chicago, Ill. This course is designed for candidates preparing for certifying and … Continue reading →

  • Zoster Virus, MS Possibly Linked

    Updated: 2011-06-10 19:00:00
    Adults with a history of chicken pox or shingles infections had a fourfold increased risk for developing multiple sclerosis, researchers said.

  • CMSC: Novel Drug Helpful in MS

    Updated: 2011-06-07 22:46:14
    MONTREAL -- Prior exposure to interferon-beta or glatiramer acetate (GA) did not seem to diminish the effectiveness of teriflunomide, the investigational multiple sclerosis drug, in a phase III trial, a researcher said.

  • CMSC: Retinal Scans Eyed for Tracking MS

    Updated: 2011-06-07 16:00:00
    MONTREAL -- A common retinal imaging technology could eventually supplement or even replace MRI scans for tracking multiple sclerosis severity and progression, researchers suggested here.

  • CMSC: Novel MS Drug May Boost Glatiramer Efficacy

    Updated: 2011-06-06 19:10:16
    MONTREAL -- Adding the investigational, oral drug teriflunomide to glatiramer acetate (GA, Copaxone) in patients with relapsing multiple sclerosis substantially decreased the MRI lesion burden, although the effect on relapse rates was less clear, a researcher said here.

Current Feed Items | Previous Months Items

May 2011 | Apr 2011 | Mar 2011 | Feb 2011 | Jan 2011 | Dec 2010